Although all genetic alterations in JAK1 identified in this study were classified as polymorphisms without amino acid changes in HCC cases, their frequency was higher than that of mutations detected in the other four genes analyzed (TP53, CTNNB1, KRAS, and AXIN1). This evidence concerns the gene KRAS and hepatocellular carcinoma.